These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8402396)

  • 1. Inhibition by nifedipine of endothelin-induced adrenal catecholamine secretion in anesthetized dogs.
    Yamaguchi N
    Can J Physiol Pharmacol; 1993; 71(3-4):301-5. PubMed ID: 8402396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of L-type Ca2+ channels in noncholinergic adrenal catecholamine secretion by endothelin-1 in vivo.
    Yamaguchi N
    Am J Physiol; 1995 Aug; 269(2 Pt 2):R287-93. PubMed ID: 7653649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of L-type Ca2+ channel in PACAP-induced adrenal catecholamine release in vivo.
    Geng G; Gaspo R; Trabelsi F; Yamaguchi N
    Am J Physiol; 1997 Oct; 273(4):R1339-45. PubMed ID: 9362297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ET(A) and ET(B) receptors in endothelin-1-induced adrenal catecholamine secretion in vivo.
    Yamaguchi N
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1290-7. PubMed ID: 9140032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evidence for L-type Ca2+ channels controlling ANG II-induced adrenal catecholamine release in vivo.
    Martineau D; Briand R; Yamaguchi N
    Am J Physiol; 1996 Dec; 271(6 Pt 2):R1713-9. PubMed ID: 8997374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine inhibits adrenal but not circulating catecholamine response to nicotinic stimulation in dogs.
    Gaspo R; Yamaguchi N; de Champlain J
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1545-51. PubMed ID: 7810764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogs.
    Gaspo R; Lamarche L; Yamaguchi N; de Champlain J; Garceau D
    Can J Physiol Pharmacol; 1992 Jul; 70(7):983-9. PubMed ID: 1451037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine.
    Kimura T; Takeuchi A; Satoh S
    Eur J Pharmacol; 1994 Oct; 264(2):169-75. PubMed ID: 7851479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic denervation reduces adrenal catecholamine secretion during insulin-induced hypoglycemia.
    Lamarche L; Yamaguchi N; Péronnet F
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R50-7. PubMed ID: 7840338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of adrenal catecholamine release by PACAP in vivo.
    Lamouche S; Martineau D; Yamaguchi N
    Am J Physiol; 1999 Jan; 276(1):R162-70. PubMed ID: 9887190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of local angiotensin-converting enzyme (ACE) in adrenal catecholamine secretion in vivo.
    Yamaguchi N; Martineau D; Lamouche S; Briand R
    Can J Physiol Pharmacol; 1999 Nov; 77(11):878-85. PubMed ID: 10593661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for adrenal catecholamine release mediated by nonnicotinic mechanism: local medullary effect of VIP.
    Yamaguchi N
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R766-71. PubMed ID: 8238445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine and Bay-K-8644 on the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation.
    Takeuchi A; Kimura T; Satoh S
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):35-9. PubMed ID: 7679341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs.
    Hosokawa A; Nagayama T; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Eur J Pharmacol; 2000 May; 397(1):55-61. PubMed ID: 10844099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by BMS 186295, a selective nonpeptide AT1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo.
    Martineau D; Yamaguchi N; Briand R
    Can J Physiol Pharmacol; 1995 Apr; 73(4):459-64. PubMed ID: 7671188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced reactivity of the adrenal medulla in response to pituitary adenylate cyclase activating polypeptide1-27 (PACAP) during insulin-induced hypoglycemia in anesthetized dogs.
    Yamaguchi N; Lamouche S
    Can J Physiol Pharmacol; 1999 Oct; 77(10):819-26. PubMed ID: 10588487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protein kinase C activator and inhibitor on adrenal catecholamine release in response to splanchnic nerve stimulation in anesthetized dogs.
    Suzuki Y; Kimura T; Satoh S
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):22-7. PubMed ID: 7521485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nifedipine and Bay K 8644 on stimulation-induced adrenal catecholamine secretion in the dog.
    Gaspo R; Yamaguchi N; De Champlain J
    Am J Physiol; 1993 Jul; 265(1 Pt 2):R28-34. PubMed ID: 7688191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that an increase in aortic norepinephrine level in response to insulin-induced hypoglycemia is due to increased adrenal norepinephrine output.
    Yamaguchi N; Briand R; Brassard M
    Can J Physiol Pharmacol; 1989 May; 67(5):499-505. PubMed ID: 2670151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland.
    Nagayama T; Kuwakubo F; Matsumoto T; Fukushima Y; Yoshida M; Suzuki-Kusaba M; Hisa H; Matsumura Y; Kimura T; Satoh S
    Eur J Pharmacol; 2000 Oct; 406(1):69-74. PubMed ID: 11011035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.